Overexpression of IL-7 enhances cisplatin resistance in glioma

References

• Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 2001; 3:152 - 8; PMID: 11465395
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987 - 96; http://dx.doi.org/10.1056/NEJMoa043330; PMID: 15758009
   PubMed Web of Science ®Google Scholar
• Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y, et al. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther 2006; 5:39 - 47; http://dx.doi.org/10.4161/cbt.5.1.2236; PMID: 16319528
   PubMed Web of Science ®Google Scholar
• Huang J, Pang J, Watanabe T, Ng HK, Ohgaki H. Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. J Mol Diagn 2009; 11:109 - 16; http://dx.doi.org/10.2353/jmoldx.2009.080143; PMID: 19197000
   PubMed Web of Science ®Google Scholar
• Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, et al. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 2001; 61:8851 - 8; PMID: 11751408
   PubMed Web of Science ®Google Scholar
• Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, et al. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 2003; 63:6784 - 90; PMID: 14583474
   PubMed Web of Science ®Google Scholar
• Wang Y, Qu Y, Niu XL, Sun WJ, Zhang XL, Li LZ. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cytokine 2011; 56:365 - 75; http://dx.doi.org/10.1016/j.cyto.2011.06.005; PMID: 21742513
   PubMed Web of Science ®Google Scholar
• Silva A, Gírio A, Cebola I, Santos CI, Antunes F, Barata JT. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells. Leukemia 2011; 25:960 - 7; http://dx.doi.org/10.1038/leu.2011.56; PMID: 21455214
   PubMed Web of Science ®Google Scholar
• Al-Rawi MA, Rmali K, Mansel RE, Jiang WG. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway. Br J Surg 2004; 91:61 - 8; http://dx.doi.org/10.1002/bjs.4449; PMID: 14716795
   PubMed Web of Science ®Google Scholar
• Karawajew L, Ruppert V, Wuchter C, Kösser A, Schrappe M, Dörken B, et al. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia. Blood 2000; 96:297 - 306; PMID: 10891465
   PubMed Web of Science ®Google Scholar
• Prasad M, Bernardini M, Tsalenko A, Marrano P, Paderova J, Lee CH, et al. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells. Genes Chromosomes Cancer 2008; 47:427 - 36; http://dx.doi.org/10.1002/gcc.20547; PMID: 18273836
   PubMed Web of Science ®Google Scholar
• Osterberg L, Levan K, Partheen K, Staaf J, Sundfeldt K, Horvath G. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cytogenet Genome Res 2009; 125:8 - 18; http://dx.doi.org/10.1159/000218744; PMID: 19617691
   PubMed Web of Science ®Google Scholar
• Hattinger CM, Reverter-Branchat G, Remondini D, Castellani GC, Benini S, Pasello M, et al. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur J Cell Biol 2003; 82:483 - 93; http://dx.doi.org/10.1078/0171-9335-00336; PMID: 14582536
   PubMed Web of Science ®Google Scholar
• Struski S, Doco-Fenzy M, Trussardi A, Masson L, Gruson N, Ulrich E, et al. Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization. Genes Chromosomes Cancer 2001; 30:136 - 42; http://dx.doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1071>3.0.CO;2-T; PMID: 11135430
   PubMed Web of Science ®Google Scholar
• Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, et al. Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer. Cancer Res 2009; 69:7793 - 802; http://dx.doi.org/10.1158/0008-5472.CAN-08-3810; PMID: 19773449
   PubMed Web of Science ®Google Scholar
• Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, Lasorsa L, et al. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis. Tumori 2009; 95:357 - 66; PMID: 19688977
   PubMed Web of Science ®Google Scholar
• de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, et al. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 2004; 13:1827 - 37; http://dx.doi.org/10.1093/hmg/ddh195; PMID: 15229187
   PubMed Web of Science ®Google Scholar
• Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005; 16:513 - 33; http://dx.doi.org/10.1016/j.cytogfr.2005.05.004; PMID: 15996891
   PubMed Web of Science ®Google Scholar
• Oka M, Hirose K, Iizuka N, Aoyagi K, Yamamoto K, Abe T, et al. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res 1995; 15:1005 - 9; http://dx.doi.org/10.1089/jir.1995.15.1005; PMID: 8590302
   PubMed Web of Science ®Google Scholar
• Maeurer MJ, Walter W, Martin D, Zitvogel L, Elder E, Storkus W, et al. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scand J Immunol 1997; 45:182 - 92; http://dx.doi.org/10.1046/j.1365-3083.1997.d01-384.x; PMID: 9042431
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Yamanouchi H, Yue Q, Ohtsuki Y. Epithelial component of lymphoid stroma-rich Warthin’s tumour expresses interleukin (IL)-7. Histopathology 1998; 32:383 - 4; http://dx.doi.org/10.1046/j.1365-2559.1998.0401h.x; PMID: 9602344
   PubMed Web of Science ®Google Scholar
• Paleri V, Pulimood A, Davies GR, Birchall MA. Interleukins 7 and 12 are expressed in head and neck squamous cancer. Clin Otolaryngol Allied Sci 2001; 26:302 - 6; http://dx.doi.org/10.1046/j.1365-2273.2001.00475.x; PMID: 11559342
   PubMed Web of Science ®Google Scholar
• Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer 2004; 40:494 - 502; http://dx.doi.org/10.1016/j.ejca.2003.10.016; PMID: 14962714
   PubMed Web of Science ®Google Scholar
• Zhao YP, Chen G, Feng B, Zhang TP, Ma EL, Wu YD. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer. Chin Med J (Engl) 2007; 120:1743 - 52; PMID: 18028764
   PubMed Web of Science ®Google Scholar
• Sade H, Sarin A. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur J Immunol 2003; 33:913 - 9; http://dx.doi.org/10.1002/eji.200323782; PMID: 12672057
   PubMed Web of Science ®Google Scholar